

MP Sharon Hodgson has been appointed Parliamentary Under-Secretary of State at the Department for Health and Social Care (DHSC), in a shake-up of ministerial roles announced on 3 March 2026 by Prime Minister Sir Keir Starmer’s administration. The move places her in a junior ministerial post within the department responsible for oversight of substantial parts of UK health policy and public health strategy.
Ms Hodgson, the Member of Parliament for Washington and Gateshead South, replaces Ashley Dalton, who stepped down from her role as health minister earlier in March to focus on her constituency duties while undergoing medical treatment. Her appointment comes at a critical time for the NHS and public health policy, with pressures ranging from workforce challenges and waiting-list backlogs to ongoing reforms in prevention and health promotion.
Role and Responsibilities
As a Parliamentary Under-Secretary of State, Ms Hodgson joins a ministerial team led by The Rt Hon Wes Streeting MP (Secretary of State for Health and Social Care) and alongside other ministers such as Karin Smyth MP, the Minister of State for Health (Secondary Care). This junior ministerial role typically involves oversight of specific policy portfolios allocated by the department, with a strong focus on public health, prevention, and community health priorities.
While the DHSC has not yet officially assigned portfolios publicly, observers and sector insiders expect that Ms Hodgson will inherit responsibilities related to public health and prevention, continuing work led previously by Ms Dalton. Broadly, this agenda includes efforts to improve population health outcomes, combat preventable disease, reduce health inequalities and elevate prevention as a core NHS strand, an orientation that has been emphasised in public discourse and NHS strategy in recent years.
Her appointment also comes against the backdrop of ongoing public health priorities such as rare disease policy implementation, mental health services, and health protection planning, which will feature in departmental discussions throughout 2026. Recent parliamentary statements show continued government focus on frameworks that support genetic therapies and rare disease centres, for example areas aligned with prevention and specialised care policy.
Political and Professional Background
Ms Hodgson has a long parliamentary career, first elected in 2004 and serving in various roles including chairing the Finance Committee. She was re-elected for the re-drawn seat of Washington and Gateshead South at the 2024 general election and has held frontbench responsibilities previously, including as Labour’s parliamentary private secretary.
Outside ministerial duties, she has been actively involved in cross-party efforts on public health issues, particularly child nutrition and school food standards, where she has campaigned on strengthening school meals and tackling food allergy safety in educational settings. These interests align closely with broader public health priorities and may inform her ministerial focus at the DHSC.
What This Means for the Health Sector
Her appointment has been welcomed by public health advocates and charities alike, which see her track record on child health and nutrition as a valuable asset in shaping preventative policy. Groups such as Natasha’s Foundation, which focuses on food allergy safety in schools and child health, expressed support and highlighted the importance of consistent leadership to ensure policies translate into real-world protections and improvements.
As Parliamentary Under-Secretary, Ms Hodgson will be expected to engage with NHS leaders, local public health authorities, third-sector stakeholders and international partners. Her role will be especially significant as the DHSC continues to balance immediate NHS operational demands with long-term efforts to improve population health and reduce pressure on acute services.
Her tenure will be watched closely by both health sector professionals and policymakers, as the government seeks to recalibrate the UK’s health agenda amid demographic change, technological innovation, and evolving public health challenges in 2026 and beyond.